InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Browse the detailed record of transactions filed by Luke Thomas Charles, Directeur Médical. Director active across 1 companies, notably SAB Biotherapeutics, Inc.. In total, 2 filings have been logged. The latest transaction was disclosed on 19 October 2021 (Attribution). Regulator: SEC (Form 4). The full history is openly available.
Declarations2 total
€8,596990 shares@ €8.683100.0% of flow
Common Stock
SEC:0001493152-21-026388·
€8,596990 shares@ €8.68350.0% of flow
Common Stock
SEC:0001493152-21-026388:0·
2 of 2 declarations
About Luke Thomas Charles
Thomas Charles Luke serves as Chief Medical Officer at SAB Biotherapeutics, Inc. In this role, he is responsible for leading the company's medical initiatives and clinical research. His medical expertise allows him to oversee the development of new treatments and ensure compliance with regulatory standards. He plays a key role in healthcare innovation and improvement.
